Lantern Pharma Inc
LTRN3.260USD
+0.020+0.62%
Close 12/19, 16:00（ET）Quotes delayed by 15 min
35.99MMarket Cap
LossP/E TTM
Lantern Pharma Inc Earnings Date
Period
FY2024 Earnings Date
Revenue(YoY)
--
--
EPS(YoY)
-1.93
-31.16%
Analyst Rating
BUY
2025-12-09
Financial Indicators
EPS
Revenue
Net Profit
Net Margin
Gross Margin
Debt to assets ratio
ROE
ROA
Relevant data have not been disclosed by the company yet.
Income Statement
Revenue
Operating profit
Net Profit
Relevant data have not been disclosed by the company yet.
Balance Sheet
Current assets
Total current liabilities
Total assets
Total liabilities
Total equity
Relevant data have not been disclosed by the company yet.
Cash Flow Statement
Net operating income
Net investment
Net financing
Relevant data have not been disclosed by the company yet.
FAQs
What is the total revenue of Lantern Pharma Inc?
According to Lantern Pharma Inc's FY2024 earnings report, its total revenue reached --, with a year-on-year change of --.
What is the Earnings Per Share (EPS) of Lantern Pharma Inc?
According to Lantern Pharma Inc's FY2024 earnings report, its Earnings Per Share (EPS) was -1.931, with a year-on-year change of -31.16%.
What is the net income of Lantern Pharma Inc?
According to Lantern Pharma Inc's FY2024 earnings report, its net income was -20.78M, with a year-on-year change of -30.20%.
What is the net margin of Lantern Pharma Inc?
According to Lantern Pharma Inc's FY2024 earnings report, its net profit margin was --, with a year-on-year change of --.
What is the gross margin of Lantern Pharma Inc?
According to Lantern Pharma Inc's FY2024 earnings report, its gross margin was --, with a year-on-year change of --.
What is the debt-to-asset ratio of Lantern Pharma Inc?
According to Lantern Pharma Inc's FY2024 earnings report, its debt-to-asset ratio was --, with a year-on-year change of --.
What is the Return on Equity (ROE) of Lantern Pharma Inc?
According to Lantern Pharma Inc's FY2024 earnings report, its Return on Equity (ROE) was -66.93%, with a year-on-year change of -103.27%.
What is the Return on Assets (ROA) of Lantern Pharma Inc?
According to Lantern Pharma Inc's FY2024 earnings report, its Return on Assets (ROA) was -60.04%, with a year-on-year change of -92.76%.
What is the operating profit of Lantern Pharma Inc?
According to Lantern Pharma Inc's FY2024 earnings report, its operating profit was -22.22M, with a year-on-year change of -24.27%.
What are the current assets of Lantern Pharma Inc?
According to Lantern Pharma Inc's FY2024 earnings report, its current assets were 25.25M, with a year-on-year change of -41.75%.
What are the total assets of Lantern Pharma Inc?
According to Lantern Pharma Inc's FY2024 earnings report, its total assets of Lantern Pharma Inc were 25.57M, with a year-on-year change of -41.41%.
What are the total liabilities of Lantern Pharma Inc?
According to Lantern Pharma Inc's FY2024 earnings report, its total liabilities of Lantern Pharma Inc were 4.38M, with a year-on-year change of 60.02%.
What is the total equity of Lantern Pharma Inc?
According to Lantern Pharma Inc's FY2024 earnings report, its total equity of Lantern Pharma Inc was 21.19M, with a year-on-year change of -48.21%.
What is the net operating income of Lantern Pharma Inc?
According to Lantern Pharma Inc's FY2024 earnings report, its net operating income of Lantern Pharma Inc was -20.78M, with a year-on-year change of -30.20%.
What is the net investment of Lantern Pharma Inc?
According to Lantern Pharma Inc's FY2024 earnings report, its net investment of Lantern Pharma Inc was 3.37M, with a year-on-year change of 462.22%.
What is the net financing of Lantern Pharma Inc?
According to Lantern Pharma Inc's FY2024 earnings report, its net financing of Lantern Pharma Inc was 66.71K, with a year-on-year change of 113.34%.
